Thailand Diabetes Drugs and Devices Market - Growth, Trends, Covid-19 Impact, and Forecasts (2024 - 2029)

Thailand's Diabetes Drugs and Devices Market is Segmented by Drugs (Insulin, Oral Anti-Diabetic Drugs, Non-Insulin Injectable Drugs, and Combination Drugs) and Devices (Management Devices (Insulin Pumps, Insulin Pens, Syringes, Cartridges, and Jet Injectors) and Monitoring Devices (Self-Monitoring Blood and Continuous Glucose Monitoring)). The Report Offers the Value (In USD) and Volume (In Unit) for the Above Segments.

Thailand Diabetes Drugs and Devices Market - Growth, Trends, Covid-19 Impact, and Forecasts (2024 - 2029)

Thailand Diabetes Drugs and Devices Industry Overview

Novo Nordisk partnered with Abbott Diabetes Care, which may also assist to enable insulin statistics to be shared between Novo Nordisk-connected insulin pens and digital fitness equipment well suited to the FreeStyle Libre portfolio of products. 

Thailand Diabetes Drugs and Devices Market Leaders

  1. Medtronics

  2. Roche

  3. NovoNordisk

  4. Sanofi

  5. Omnipod

  6. *Disclaimer: Major Players sorted in no particular order
Thailand Diabetes Drugs and Devices Market Concentration

Thailand Diabetes Drugs and Devices Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?